Cost-utility analysis of valsartan, enalapril, and candesartan in patients with heart failure in Iran
Abstract Background Today, heart failure is one of the leading causes of death and disability in most developed and developing countries. By 2030, more than 23.3 million people are projected to die of cardiovascular diseases each year, and the prevalence of heart failure is expected to increase by 2...
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
BMC
2023-09-01
|
| Schriftenreihe: | Health Economics Review |
| Schlagworte: | |
| Online-Zugang: | https://doi.org/10.1186/s13561-023-00457-4 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|